Global medical aesthetics company JETEMA announced on the 21st that it has completed the 'JETEMA Speaker Invitation Seminar' held for its employees at the Pangyo Global R&D Center.
This seminar was designed to increase employees’ understanding of the latest trends and product characteristics in the filler and botulinum toxin market and to provide practical assistance in establishing future sales and marketing strategies.
At the seminar, Director Hong Han-bit, who is the senior academic director of the Korean Society of Lifting Surgery and the director of Luxwell Clinic, participated as a speaker and gave a lecture on the topic of ‘Teoxan RHA filler treatment method for a natural facial appearance after treatment.’
In his lecture, Director Hong explained, “Initial inflammation that occurs immediately after filler treatment can be a major cause of shape deformation, but Teoxan RHA filler has the characteristic of minimizing the creation of hyaluronic acid fragments and reducing the occurrence of inflammation through a crosslinking process that gently mixes without applying heat.” Teoxan RHA filler is manufactured through a process that maintains high molecular weight hyaluronic acid raw materials, and is known to induce autologous collagen synthesis and implement natural volume.
Along with this, the competitiveness of Jetema's botulinum toxin product 'Jetemader Toxin' and its positioning strategy in the domestic market were also introduced. Director Hong evaluated, "Jetemader Toxin is a premium toxin product that can be strategically differentiated in the Korean market, which is an advanced beauty market."
Jetemadertoxin is manufactured based on a strain donated by a European accredited institution, and is a high-purity, high-activity botulinum toxin that uses the latest patented purification technology. It is known as a product that exhibits rapid onset and excellent effectiveness.
Jetema plans to strengthen its employees’ product understanding and market response capabilities through continuous internal education, including this seminar, and to lay a strategic foundation for securing competitiveness in the global market.
A Jetema official said, “Internal training is one of the key elements for realizing the corporate vision,” and “We expect that continuous strengthening of expertise will contribute to Jetema’s leadership in the global medical aesthetics market.”
- See more related articles
You must be logged in to post a comment.